A study looks at the efficacy of aspirin in reducing preterm preeclampsia. Plus: The CDC reports on antidepressant use in the United States. Also, a look at whether vaginal estrogen postmenopause increases the risk of heart disease and certain types of cancer.
This article reviews how migraines in women are impacted by the fluctuating hormone levels they experience throughout their lifecycle.
A first-of-its-kind capsule combining natural 17β-estradiol and progesterone has promise for menopause-related hot flushes, according to results of a Phase 3 multi center trial.
Dr Greenberg reports his thoughts on the Sureglide device and preventing lacerations during cesarean, Überlube and helping women with vaginal dryness and dyspareunia, and TruClear ULTRA Mini tissue removal device for mechanical morcellation.
Can adopting quality measures decrease the cesarean rate? Plus: The Government Accountability Office issues a report on power morcellators and the FDA's system of evaluation. Also, does the volume of one type of heart fat indicate the risk of heart disease?
2016 was a year of change and new challenges. Find out what the top news stories of 2016 were.
A study examines the efficacy of lower-than-conventional doses of estrogen in relieving vasomotor symptoms. Plus: What are the latest ACOG recommendations on water births?
A new study looks at the impact of hormone replacement therapy on preventing Alzheimer's. Plus: Are breast density readings actually accurate?
Are women who exposed to flame retardants at greater risk of thyroid disease? Plus: A look at the potential connection between maternal smoking status and risk of the child developing schizophrenia. Also, can telephone therapy help menopausal women get better sleep?
A new study looks at whether ovary-sparing hysterectomies can lead to early menopause. Plus: Does betamethasone reduce respiratory complications in preterm infants? Also, the impact of the vaginal microbiome on preterm birth.
The FDA approves the first containment system for morcellation. Plus: ASRM provides guidance for Zika virus. And, the impact of HRT timing and its impact on cardiovascular disease.
Do women suffer from more migraines as they transition into menopause? Plus: A report indicates that hospitals may not be adequately supporting breastfeeding in teenaged mothers. And, a look at prenatal exposure to bronchodilators and autism.
Osteoporosis and tooth loss are linked in postmenopausal women, a small study finds.
A new study looks at whether or not the HPV vaccine increases miscarriage risk. And, is there a link between nocturnal enuresis and sleep apnea in postmenopause? Plus: The impact of the Mediterranean diet on breast cancer risk.
Have pelvic guideline changes led to a reduction in other recommended screenings? Plus, how does menopause impact future cardiovascular health? And: Does childhood stress lead to negative obstetric outcomes?
Using SSRI late in pregnancy may increase the risk of persistent pulmonary hypertension in a newborn. Plus, hormone therapy may help mood in early postmenopause; use of mesh for prolapse on the rise
Plus: research on systemic HT, type II diabetes and post-pregnancy obesity
New research identifies 3 factors that may play a role in menopause-related storage lower urinary tract symptoms, or incontinence.
The GnRH agonist goserelin, when given during chemotherapy, may protect against ovarian failure and early menopause in women with breast cancer.
Hormone replacement therapy won't protect postmenopausal women against stroke or heart disease, but don't discount it for symptoms of menopause just yet.
Women with hot flashes related to menopause carry the burden of these symptoms, but new research highlights the economic toll if left untreated.
Women taking compounded bioidentical hormones for symptoms of menopause don't know as much as they should about the therapy.
A review of the latest research on the persistence of vasomotor symptoms, the link between hormone therapy and ovarian cancer risk, and the prevalence of substance use in pregnant adolescents.
New research shows hot flashes last longer than once thought, and when they begin can indicate how long hot flashes will linger.
Even brief use of hormone replacement therapy in menopause can increase risk of the 2 most common forms of ovarian cancer, a meta-analysis finds.
